Koelis Announces Innovative Products at EAU 2025 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer
March 20, 2025 07:00 ET
|
Koelis
GRENOBLE, France, March 20, 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a global leader and innovator in urology and prostate care, announced today it is...
Andromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical Development
March 05, 2025 14:07 ET
|
Andromeda Surgical
Andromeda Surgical announces partnerships with Quanta System and Richard Wolf.
Nitinol-Based Medical Device Market to Reach $9.8 billion, Globally, by 2035 at 7.1% CAGR: Allied Market Research
February 19, 2025 06:26 ET
|
Allied Market Research INC
Wilmington, Delaware, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Nitinol-Based Medical Device Market by Product Type (Stents, Guidewires, Retrieval device,...
Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration
February 05, 2025 08:30 ET
|
Myriad Genetics, Inc.
Myriad Genetics and Lumea have signed an agreement to enhance access to the Prolaris and MyRisk Hereditary Cancer tests through BxLink integration.
Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research
January 16, 2025 20:15 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Medical lasers are light-emitting devices used for treating or removing tissues. Non-ionizing radiation decreases blood loss, alleviates...
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025 09:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, has partnered with USSM, an...
NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment
December 09, 2024 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced Prolaris prostate cancer prognostic test is classified by the NCCN as an advanced tool in the fight against prostate cancer.
Correction: AUA Announces 2025 Distinguished Awards Recognizing Top Urologists
December 04, 2024 14:03 ET
|
American Urological Association
BALTIMORE, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) announced today the list of 2025 award recipients recognizing top urologists in the field. The winners will be...
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
October 17, 2024 06:45 ET
|
Teleflex Incorporated
• Barrigel™ rectal spacer provides high quality rectal spacing, enabling low dose to the rectum during prostate cancer radiation therapy, with an excellent toxicity and safety profile; and low...
Verana Health Announces Launch of Qdata® BPH
October 01, 2024 09:00 ET
|
Verana Health, Inc.
SAN FRANCISCO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today...